The role of glia in the mechanisms of neural protection of the fixed combination of ipidacrine hydrochloride / phenibut on the background of drug-induced liver injury




ipidacrine hydrochloride, phenibut, drug-induced liver injury, hippocampus


Topicality. The main disadvantage of the first-line anti-TB drugs isoniazid and rifampicin is their ability to cause drug-induced liver injury. At the same time, in addition to hepatotoxic, in 12-24 % of cases are neurological disorders. The consequence of these processes is a disturbance of synaptic plasticity, learning processes and memory. In addition, significant factor in the development of neurological disorders may be an imbalance of intestinal microflora. One of the possible options at eliminating or attenuating the manifestations of cognitive deficiency in various pathological conditions is the appointment of drugs with neuroprotective properties. However, even today their effectiveness studied not enough for central nervous system dysfunctions arising from prolonged anti-TB therapy. Therefore, we can assume that neurological disorders can be due to a complex of interrelated factors.
Aim. To determine the morphometric and ultrastructural features of neurons and glial cells, as well as the levels of glial fibrillary acid protein (GFAB) in the hippocampus of rats under long-term administration of isoniazid and rifampicin during experimental therapy with a fixed combination of ipidacrine hydrochloride/phenibut.
Materials and methods. Studies were conducted on three groups of white Wistar male rats with drug-induced hepatitis, reproduced by intragastric administration of isoniazid and rifampicin for 28 days. In the last 14 days of the intragastric experiment, rats of the research group were administered ipidacrine hydrochloride/phenibut (1/60 mg/kg). The content of cytosolic GFAP in the hippocampus was determined by competitive enzyme-linked immunosorbent assay. Semi-thin sections of CA1 sections of the rat hippocampus were analyzed, Image J. analysis program used. The ultrastructural characteristics were studied, PEM-100-01 transmission electron microscope used (Selmi, Ukraine).

Results and discussion. Under the experimental pharmacotherapy the specific number of degeneratively altered neurons was significantly lower than in the controlled animals. At the same time, astrocytes were characterized by significantly less edema of the cytoplasm and adaptive-compensatory changes in mitochondria, and the content of cytoplasmic GFAP was 44.2 % (P = 0.0065) lower than the group of animals with hepatitis.

Conclusions. Course administration of ipidacrine and phenibut reduces the severity of neurodegeneration appearance, improves the state of astroglia in the hippocampus, and it also reduces the cytoplasmic levels of glial acidic fibrillary protein in animals with drug-induced liver injury.

Author Biographies

Yu. Kharchenko, State Institution "Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine"

lecturer of the Department of Pharmacology and Clinical Pharmacology

N. Bondarenko, State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”

PhD, Associate Professor of the Department of Pathological Anatomy and Forensic Medicine

A. Serdiuk, State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”


G. Ushakova, Oles Honchar Dnipro National University

PhD, Doctor of Science, Professor, Head of the Department of Biophysics and Biochemistry

V. Zhyliuk, State Institution “Dnipropetrovsk Medical Academy of the Ministry of Health of Ukraine”

PhD, Doctor of Science, Professor, Head of the Department of Pharmacology and Clinical Pharmacology


Shih, T.-Y., Young, T.-H., Lee, H.-S., Hsieh, C.-B., & Hu, O. Y.-P. (2013). Protective Effects of Kaempferol on Isoniazid- and Rifampicin-Induced Hepatotoxicity. The AAPS Journal, 15 (3), 753–762.

Wang, C., Fan, R.-Q., Zhang, Y.-X., Nie, H., & Li, K. (2016). Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury. World Journal of Gastroenterology, 22 (44), 9775.

Wang, P., Pradhan, K., Zhong, X., & Ma, X. (2016). Isoniazid metabolism and hepatotoxicity. Acta Pharmaceutica Sinica B, 6 (5), 384–392.

Hakim, Z., Waheed, A., Bakhtiar, S., Hasan, N., Hakim, B. (2018). Potentiating effect of rifampicin on methimazole induced hepatotoxicity in mice. Pak J Pharm Sci., 31 (6), 2373–2377.

Ridola, L., Nardelli, S., Gioia, S., & Riggio, O. (2018). Quality of life in patients with minimal hepatic encephalopathy. World Journal of Gastroenterology, 24 (48), 5446–5453.

Tyulkova, T. E. (2018). Effect of pyridoxine and isonicotinic acid hydrazide on the nervous system during tuberculosis treatment. Tuberculosis and lung diseases, 96 (11), 69–73.

Verdi, S., Jackson, M. A., Beaumont, M., Bowyer, R. C. E., Bell, J. T., Spector, T. D., & Steves, C. J. (2018). An Investigation Into Physical Frailty as a Link Between the Gut Microbiome and Cognitive Health. Frontiers in Aging Neuroscience, 10.

Namasivayam, S., Maiga, M., Yuan, W., Thovarai, V., Costa, D. L., Mittereder, L. R., … Sher, A. (2017). Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome, 5 (1).

Wipperman, M. F., Fitzgerald, D. W., Juste, M. A. J., Taur, Y., Namasivayam, S., Sher, A., … Glickman, M. S. (2017). Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Scientific Reports, 7 (1).

Bielenichev, I. F. (2015). Zaporozhskyi medytsynskyi zhurnal, 2(89), 37–41.

Smirnov, A. V., Kraiushkin, A. I., Gorelik, E. V., Gurov, D. Iu., Grigoreva, N. V., Zamaraev, V. S., Danilenko, V. I. (2012). Sovremennye problemy nauki i obrazovaniia, 1.

Assonov, D. O., & Bozhuk, B. S. (2017). Role of the hippocampus in memory functioning: modern view. Zaporozhye Medical Journal, 6.

Gomazkov, O. A. (2018). Uspekhi Sovremennoi Biologii, (4), 373–382.

Gomazkov, O. A. (2019). Neirokhimiia, 36 (4), 267–274.

Kovalchuk, Y. P., & Ushakovа, H. O. (2016). The changes of glial fibrillary acid protein level in the different brain areas of gerbils under development, aging and alpha-keto glutarate effect. Medical and Clinical Chemistry, (1).

Chorna, V. I., Lianna, O. L. (2011). Ukrainskyi radiolohichnyi zhurnal, 2, 238–242.

Kyrychenko, S., Prishchepa, I., Lagoda, V., Velika, M., & Nedzvetsky, V. (2014). Neuroprotective effects of α-lipoic acid on the development of oxidative stress and astrogliosis in the brain of STZ-diabetic rats. Visnyk of Dnipropetrovsk University. Biology, Medicine, 5 (2), 143–147.

Chorna, V. I., Drozdov, A. L. (2006). Neirokhymyia, 1, 47–51.

Council Directive 2010/63/EU of 22 September 2010 on the protection of animals used for scientific purposes. (2010). Official Journal of the European

Communities. Available at:

Dobrelia, N. V., Strielkov, Ye. V., Bukhtiarova, T. A. (2014). Farmakolohiia ta likarska toksykolohiia, 2 (38), 88–91.

Berezhna, L. H., Kovalenko, V. M., Shaiakhmetova, H. M., Voronina, A. K., Voloshyna, O. S. (2005). Suchasni problemy toksykolohii, 3, 54–58.

Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72 (1-2), 248–254.

Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012). NIH Image to ImageJ: 25 years of image analysis. Nature Methods, 9 (7), 671–675.

Nedzvetskyi, V. S. (2004). Fiziolohichnyi zhurnal, 50(1), 85–90.

Fomenko, O. Z., Ushakova H. O., Piierzhynovskyi S. H. (2011). Ukrainskyi biokhimichnyi zhurnal, 83 (1), 69–76.





Pharmacology and biochemistry